Our impact
Operating with integrity, promoting environmental responsibility and fostering a diverse and inclusive workplace where our employees can thrive

Close up of persons eye

Environmental, Social and Governance (ESG) at Bioscript Group

As a business, we are dedicated to fully integrating sustainability into our operations.

To ensure we remain on the right path, we have participated in the EcoVadis ESG benchmark for the past 5 years. EcoVadis evaluates our sustainability performance, and our results have shown a year-on-year improvement.

We retained our silver certificate, placing us in the 88th percentile of all companies evaluated by EcoVadis. This demonstrates our commitment and significant progress in this particular area.

Our dedicated ESG Steering Committee directs and steers all ESG matters.

30%

Down arrow navy icon

We measure our carbon footprint annually, and in 2025 we achieved a 30% reduction in overall emissions compared with our 2023 baseline.

Transparency is at the heart of our climate commitment. Our 2025 GHG emissions inventory has been independently verified to the ISO 14064 standard by Carbonology®, a UKAS-accredited verification body.

42%

In 2024, we publicly declared our Science Based Targets (SBT) to reduce our Scope 1 and 2 emissions by 42% by 2030 from a 2023 base year. In 2025 our Scope 1 and 2 emissions are effectively zero. We have set targets for our pathway that takes us to Net Zero by 2045.

Leaf white icon

In 2025, we consolidated our offices, resulting in all our UK offices now using renewable energy and eliminating our reliance on gas. We continue to explore other ways to positively impact the environment.

Windturbines
Birds eye view of land
Bodycote
The Seashell Trust group volunteering day
Lady and man chatting
Three colleague meeting at a small table
We take pride in the significant strides we have made in ESG initiatives and are committed to continue to work with our clients, suppliers and partners to make a positive difference towards sustainability
Gabrielle Silver, CEO of Bioscript Group